APA (7th ed.) Citation

Y, S., K, W., M, M., Y, Y., K, Y., K, S., . . . Y, B. (2026). Capmatinib for High-Level MET-Amplified Metastatic Gastric Cancer Identified by Comprehensive Genomic Profiling: A Case Report and Literature Review. Journal of gastrointestinal cancer, 57(1), . https://doi.org/10.1007/s12029-026-01561-4

Chicago Style (17th ed.) Citation

Y, Sato, Watanabe K, Matsuoka M, Yamada Y, Yagi K, Sunami K, Ogawa M, Oda K, and Baba Y. "Capmatinib for High-Level MET-Amplified Metastatic Gastric Cancer Identified by Comprehensive Genomic Profiling: A Case Report and Literature Review." Journal of Gastrointestinal Cancer 57, no. 1 (2026). https://doi.org/10.1007/s12029-026-01561-4.

MLA (9th ed.) Citation

Y, Sato, et al. "Capmatinib for High-Level MET-Amplified Metastatic Gastric Cancer Identified by Comprehensive Genomic Profiling: A Case Report and Literature Review." Journal of Gastrointestinal Cancer, vol. 57, no. 1, 2026, https://doi.org/10.1007/s12029-026-01561-4.